Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Melanie Hohberg"'
Autor:
Melanie Hohberg, Carsten Kobe, Philipp Krapf, Philipp Täger, Jochen Hammes, Felix Dietlein, Boris D. Zlatopolskiy, Heike Endepols, Markus Wild, Stephan Neubauer, Axel Heidenreich, Bernd Neumaier, Alexander Drzezga, Markus Dietlein
Publikováno v:
EJNMMI Research, Vol 9, Iss 1, Pp 1-10 (2019)
Abstract Aim We investigated the whole-body distribution and the radiation dosimetry of [18F]-JK-PSMA-7, a novel 18F-labeled PSMA-ligand for PET/CT imaging of prostate cancer. Methods Ten patients with prostate cancer and biochemical recurrence or ra
Externí odkaz:
https://doaj.org/article/a69f0d440c4d48738aee1058c47e055d
Autor:
Jochen Hammes, Lutz van Heek, Melanie Hohberg, Manuel Reifegerst, Simone Stockter, Markus Dietlein, Markus Wild, Alexander Drzezga, Matthias Schmidt, Carsten Kobe
Publikováno v:
EJNMMI Physics, Vol 5, Iss 1, Pp 1-10 (2018)
Abstract Purpose Radioiodine has been used for the treatment of benign thyroid diseases for over 70 years. However, internationally, there is no common standard for pretherapeutic dosimetry to optimally define the individual therapy activity. Here, w
Externí odkaz:
https://doaj.org/article/8f2aac24142b4c79a28499d7b2e2e614
Autor:
Jochen Hammes, Melanie Hohberg, Philipp Täger, Markus Wild, Boris Zlatopolskiy, Philipp Krapf, Bernd Neumaier, Klaus Schomäcker, Carsten Kobe, Matthias Schmidt, Markus Dietlein, Alexander Drzezga
Publikováno v:
PLoS ONE, Vol 13, Iss 12, p e0209613 (2018)
INTRODUCTION:[68Ga]PSMA-HBED-CC and [18F]DCFPyL show a high potential for the detection of recurrent prostate cancer. While 18F-based tracers have several advantages in availability and image resolution, their sensitivity in the skeleton might be imp
Externí odkaz:
https://doaj.org/article/d448f68b98c84a4dafa167e89169dbfb
Autor:
Ralph A. Bundschuh, Markus Essler, Julia Dinges, Christian Berchtenbreiter, Jan Mariss, Axel Martínez-Möller, Gaspar Delso, Melanie Hohberg, Stephan G. Nekolla, Dominik Schulz, Sibylle I. Ziegler, Markus Schwaiger
Publikováno v:
Molecular Imaging, Vol 9 (2010)
Positron emission tomography-computed tomography (PET-CT) is superior compared to stand-alone PET in evaluation of malignancies. Few studies have employed high-resolution structural information to correct PET. We designed a semiautomatic algorithm us
Externí odkaz:
https://doaj.org/article/f95d593388d141feb3abdf83be500994
Autor:
Markus Dietlein, Manuel Reifegerst, Felix Dietlein, Alexander Drzezga, Bernd Neumaier, Melanie Hohberg, Heike Endepols, Carsten Kobe, Thomas Fischer, Klaus Schomaecker, Sergio Muñoz Vázquez
Publikováno v:
Journal of nuclear medicine 63(4), 573-583 (2022). doi:10.2967/jnumed.121.262290
The short half-life of existing prostate-specificmembraneantigen (PSMA) tracers limits their time for internalization into tumor cells after injection, which is an essential prerequisite for robust detection of tumor lesions with low PSMA expression
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9720120faee6cce503530b7f7003fe29
https://doi.org/10.2967/jnumed.121.262290
https://doi.org/10.2967/jnumed.121.262290
Autor:
Felix Dietlein, Philipp Krapf, Bernd Neumaier, Boris D. Zlatopolskiy, Peter Mueller, Carsten Kobe, Axel Heidenreich, Alexander Drzezga, Markus Dietlein, Melanie Hohberg, Heike Endepols
Publikováno v:
Molecular imaging and biology 23(2), 277-286 (2020). doi:10.1007/s11307-020-01546-0
Molecular Imaging and Biology
Molecular Imaging and Biology
Purpose PSMA imaging is frequently used for monitoring of androgen deprivation therapy (ADT) in prostate cancer. In a previous study, [18F]-JK-PSMA-7 exhibited favorable properties for tumor localization after biochemical recurrence. In this retrospe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfa60094ec09017da145c690e63f1b17
https://doi.org/10.1007/s11307-020-01546-0
https://doi.org/10.1007/s11307-020-01546-0
Autor:
Beate Zimmermanns, Heike Endepols, Melanie Hohberg, Felix Dietlein, Klaus Schomäcker, Bernd Neumaier, Alexander Drzezga, Samir-Ghali Tawadros, Sergio Muñoz Vázquez, Markus Dietlein, Thomas Fischer
Publikováno v:
Molecular imaging & biology 24, 115-125 (2022). doi:10.1007/s11307-021-01632-x
Molecular Imaging and Biology
Molecular Imaging and Biology
PurposeWe present here a Zr-89-labeled inhibitor of prostate-specific membrane antigen (PSMA) as a complement to the already established F-18- or Ga-68-ligands.ProceduresThe precursor PSMA-DFO (ABX) was used for Zr-89-labeling. This is not an antibod
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e67def17b2b4bf2fb05180800a1e19d1
https://juser.fz-juelich.de/record/904399
https://juser.fz-juelich.de/record/904399
Autor:
Philipp Täger, Alexander Drzezga, Melanie Hohberg, Felix Dietlein, Philipp Krapf, Markus Dietlein, Axel Heidenreich, Bernd Neumaier, Jochen Hammes, Heike Endepols, Boris D. Zlatopolskiy, Carsten Kobe
Publikováno v:
Journal of nuclear medicine 61(2), 202-209 (2020). doi:10.2967/jnumed.119.229542
In preclinical trials, the recently developed tracer 2-methoxy-18F-DCFPyL (18F-JK-prostate-specific membrane antigen [PSMA]-7) has shown favorable properties regarding clinical performance and radiochemical accessibility. The aim of this study was to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16c3e6d7cdff8fe1f9bba0929f7b6b64
https://doi.org/10.2967/jnumed.119.229542
https://doi.org/10.2967/jnumed.119.229542
Autor:
Simone Stockter, Melanie Hohberg, Markus Dietlein, Carsten Kobe, Manuel Reifegerst, Jochen Hammes, Lutz van Heek, Markus Wild, Alexander Drzezga, Matthias Schmidt
Publikováno v:
EJNMMI Physics, Vol 5, Iss 1, Pp 1-10 (2018)
EJNMMI Physics
EJNMMI Physics
Purpose Radioiodine has been used for the treatment of benign thyroid diseases for over 70 years. However, internationally, there is no common standard for pretherapeutic dosimetry to optimally define the individual therapy activity. Here, we analyze
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a05b306e6dd87126d95b2b3d31808e2
http://link.springer.com/article/10.1186/s40658-018-0231-x
http://link.springer.com/article/10.1186/s40658-018-0231-x
Autor:
Felix, Dietlein, Carsten, Kobe, Sergio Muñoz, Vázquez, Thomas, Fischer, Heike, Endepols, Melanie, Hohberg, Manuel, Reifegerst, Bernd, Neumaier, Klaus, Schomäcker, Alexander E, Drzezga, Markus, Dietlein
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 63(4)
The short half-life of existing prostate-specific membrane antigen (PSMA) tracers limits their time for internalization into tumor cells after injection, which is an essential prerequisite for robust detection of tumor lesions with low PSMA expressio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::329f02f02f5495d5643fc0895c9f68b1
https://pubmed.ncbi.nlm.nih.gov/34326129
https://pubmed.ncbi.nlm.nih.gov/34326129